Regulatory Provenance FDA cleared non-surgical device for pain treatment targeting herniated and degenerative disc conditions, manufactured under ISO 13485. This positions the company as a compliant, hospital- and clinic-ready partner for medical device procurement.

Small Team Advantage With a lean 2-10 employee base, opportunities exist to upsell through scalable service packages, extended training, and streamlined procurement processes that align with rapid decision cycles common in small to midsize clinics.

Pain Management Focus Extentrac Elite addresses common spine and facet syndrome pain, offering a non-surgical option that can complement or replace certain procedures, creating cross-sell potential with orthopedic, pain management, and physical therapy practices.

Manufacturing Footprint Located in the Hauppauge Industrial Park, New York, the facility may enable nearshore logistics for U.S.-based hospitals and clinics seeking domestic manufacturing and faster delivery timelines.

Growth Readiness Revenue range indicates scalable growth potential; use this to tailor vendor partnerships, distribution agreements, and channel strategies with mid-market PT clinics, outpatient centers, and regional hospital networks that value ISO 13485 quality assurance.